Joseph K. Agyin, Ph.D., University of Texas Health Science Center, San Antonio, TX. Abstract #6462. A novel proteasome inhibitor for multiple myeloma and other cancers.
Sylvette Ayala-Torres, Ph.D., Univ. Central del Caribe School of Medicine, Bayamón, PR. Abstract #1969. 25-hydroxycholesterol induces mitochondrial DNA damage and dysfunction in the human leukemic CEM cells.
Wellington K. Ayensu, M.D., Jackson State University, Jackson, MS. Abstract #3718. In vitro expression of glycine apha-3, GABA-A, and glutamate-gated chloride channel receptors in HepG2 pon low level exposure to mercury.
Antonio T. Baines, Ph.D., University of North Carolina, Chapel Hill, NC.
Lisa L. Baumbach, Ph.D., Univ. of Miami School of Medicine, Miami, FL. Abstract #395. Development and implementation of a first-tier BRCA1/BRCA2 mutation screening panel in women of African ancestry.
Hassan Brim, Ph.D., Howard University, Washington, DC.
Jaideep Chaudhary, Ph.D., Clark Atlanta University, Atlanta, GA. Abstract #1150. The helix loop helix protein Id4 is epigenetically silenced in prostate cancer cells: Ectopic Id4 expression induces androgen receptor expression (AR) and response in AR negative prostate cancer cells.
Xiaoxin (Luke) Chen, M.D., Ph.D., North Carolina Central University, Durham, NC.
Yong Cui, M.D., Meharry Medical College, Nashville, TN. Abstract #790. Factors associated with participation, initial quit and six-month relapse in a smoking cessation program for veterans.
Selina F. Darling-Reed, Ph.D., Florida A&M University, Tallahassee, FL. Abstract #3346. Akt phosphorylation attenuated by trans-Resveratrol: A strategy for mammary cancer intervention Benzo(a)pyrene and Diallyl Sulfide Induces GST and SOD Activity in MCF-10A Cells.
Surangani F. Dharmawardhane Flanagan, Ph.D., Univ. Central del Caribe, Bayamón, PR.
Wayne A.I. Frederick, M.D., F.A.C.S., Howard University, Washington, DC.
Minnie Q. Holmes-McNary, Ph.D., North Carolina A&T State University, Greensboro, NC. Abstract #4199. Akt phosphorylation attenuated by trans-Resveratrol: A strategy for mammary cancer intervention.
Shubha K. Ireland, Ph.D., Xavier University, New Orleans, LA.
Ward G. Kirlin, Ph.D., Morehouse School of Medicine, Atlanta, GA.
Nameer B. Kirma, Ph.D., UT Health Science Center, San Antonio, TX.
Babatunde O. Oyajobi, M.D., Ph.D., UT Health Science Center, San Antonio, TX.
Anita K Patlolla, Ph.D., Jackson State University, Jackson, MS. Abstract #891. DNA damaging effects of potassium dichromate in peripheral blood leukocytes of Sprague-Dawley rats.
Romonia R. Reams, Ph.D., Florida A&M University, Tallahassee, FL.
Gary L. Sanford, Ph.D., Morehouse School of Medicine, Atlanta, GA.
Martha Verghese, Ph.D., Alabama A&M University, Normal, AL.
Karen M. Williams, Ph.D., Howard University, Washington, DC.
Myron N. Williams, Ph.D., Clark Atlanta University, Atlanta, GA. Abstract #2047. Metastatic potential influences down-regulation of E-cadherin shedding by prostate cancer cells in response to hypoxia.
Teshome E. Yehualaeshet, D.V.M., Ph.D., Tuskegee University, Tuskegee, AL. Abstract #5544. Inhibitory effects of benzyl isothiocyanate on the proliferation of prostate and breast cancer cells.
Reema R. Zeineldin, Ph.D., Univ. of New Mexico College of Pharmacy, Albuquerque, NM. Abstract #2071. Expression of EGFRvIII in ovarian cancer cells leads to constitutive activation of erbB2.